Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc De Hert

Showing results (171-180 of 254) with videos related to

Pageof 26
Sort By:
The Pan African Medical Journal|May 12, 2017
A systematic review of physical activity policy recommendations and interventions for people with mental health problems in Sub-Saharan African countriesDavy Vancampfort, Brendon Stubbs, Marc De Hert, et al.
The American Journal of Psychiatry|January 31, 2013
Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderatorsDavy Vancampfort, Kristof Vansteelandt, Christoph U Correll, et al.
Schizophrenia Research|December 13, 2012
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidonePeter Manu, Christoph U Correll, Martien Wampers, et al.
Schizophrenia Research|August 23, 2012
Genetic association study of the P300 endophenotype in schizophreniaJeroen Decoster, Marc De Hert, Wolfgang Viechtbauer, et al.
Therapeutic Advances in Psychopharmacology|April 2, 2021
Defining polypharmacy: in search of a more comprehensive determination method applied in a tertiary psychiatric hospitalJeroen Govaerts, Julie Boeyckens, Astrid Lammens, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 8, 2021
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus studySilvana Galderisi, Marc De Hert, Stefano Del Prato, et al.
Schizophrenia Research|August 3, 2010
Effects of cannabis use on age at onset in schizophrenia and bipolar disorderMarc De Hert, Martien Wampers, Tihana Jendricko, et al.
Schizophrenia Research|July 9, 2013
Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysisAmber De Herdt, Martien Wampers, Davy Vancampfort, et al.
Journal of the American Medical Directors Association|April 24, 2020
Risk of Hospitalized Falls and Hip Fractures in 22,103 Older Adults Receiving Mental Health Care vs 161,603 Controls: A Large Cohort StudyBrendon Stubbs, Gayan Perara, Ai Koyanagi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2011
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label studyMartien Wampers, Linda Hanssens, Ruud van Winkel, et al.
Pageof 26

Showing results (171-180 of 254) with videos related to

Sort By:
Pageof 26
The Pan African Medical Journal|May 12, 2017
A systematic review of physical activity policy recommendations and interventions for people with mental health problems in Sub-Saharan African countriesDavy Vancampfort, Brendon Stubbs, Marc De Hert, et al.
The American Journal of Psychiatry|January 31, 2013
Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderatorsDavy Vancampfort, Kristof Vansteelandt, Christoph U Correll, et al.
Schizophrenia Research|December 13, 2012
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidonePeter Manu, Christoph U Correll, Martien Wampers, et al.
Schizophrenia Research|August 23, 2012
Genetic association study of the P300 endophenotype in schizophreniaJeroen Decoster, Marc De Hert, Wolfgang Viechtbauer, et al.
Therapeutic Advances in Psychopharmacology|April 2, 2021
Defining polypharmacy: in search of a more comprehensive determination method applied in a tertiary psychiatric hospitalJeroen Govaerts, Julie Boeyckens, Astrid Lammens, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 8, 2021
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus studySilvana Galderisi, Marc De Hert, Stefano Del Prato, et al.
Schizophrenia Research|August 3, 2010
Effects of cannabis use on age at onset in schizophrenia and bipolar disorderMarc De Hert, Martien Wampers, Tihana Jendricko, et al.
Schizophrenia Research|July 9, 2013
Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysisAmber De Herdt, Martien Wampers, Davy Vancampfort, et al.
Journal of the American Medical Directors Association|April 24, 2020
Risk of Hospitalized Falls and Hip Fractures in 22,103 Older Adults Receiving Mental Health Care vs 161,603 Controls: A Large Cohort StudyBrendon Stubbs, Gayan Perara, Ai Koyanagi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 23, 2011
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label studyMartien Wampers, Linda Hanssens, Ruud van Winkel, et al.
Pageof 26